Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-25

Clinical Trial Update: Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial update on zinc supplementation in patients with beta-thalassemia major complicated with diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zinc supplementation (zinc)

Snippet

Sponsor: Ain Shams University | Conditions: Beta-thalassemia Major Complicated With Diabetes | Phase 3 | Status: COMPLETED